This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Abiomed Provides Multi-Year Grant To Boston Children's Hospital Heart Center

Stocks in this article: ABMD

DANVERS, Mass., Oct. 1, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today reported its donation of an unrestricted grant in the amount of $375,000 to Boston Children's Hospital Heart Center, a newly dedicated cardiovascular care center founded within Boston Children's Hospital.

The Boston Children's Hospital Heart Center integrates all pediatric specialists related to a patient's care in order to treat both the heart and the whole child. This organizational structure allows for a more focused clinical approach and a fully aligned research effort so that new therapies have the best chance of treating today's patients. Abiomed's funding will help support research and education initiatives of the Heart Center's Advanced Cardiac Therapies (ACT) Program.   Among the uses of these funds, the following scientific and clinical goals will be pursued:

  • Advance the understanding of basic pathophysiology and symptom correlation in pediatric acute decompensated heart failure patients.
  • Engage key opinion leaders to assess the potential for multi-center registries and improved methodologies for monitoring neurologic function and quality of life for pediatric patients who receive mechanical circulatory support. 
  • Investigate new cellular and genomic cardiac regeneration therapies that will stimulate myocardial recovery.

"We are very thankful for Abiomed's generosity in providing this gift to Boston Children's Hospital Heart Center," said Sandra Fenwick, President and Chief Executive Officer, Boston Children's Hospital. "Boston Children's is a leader and innovator in pediatric cardiology and heart surgery. This grant from Abiomed, supporting our scientific and clinical goals, will help us advance the care of children with advanced heart failure.

Boston Children's Hospital Heart Center is one of the nation's most active pediatric heart failure and transplant centers, managing some of the most complex pediatric and adult congenital heart failure cases in the world and is consistently ranked number one in Pediatric Cardiology and Heart Surgery by US News & World Report.

"We are very excited about this area of research for pediatric heart failure patients. Abiomed is pleased to support Boston Children's research and advancements for new, cutting edge technologies in the field of pediatric cardiac care," said Michael R. Minogue, Chairman, President and Chief Executive Officer of Abiomed.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs